Elekta AB (OTCMKTS:EKTAY) Stock Short Interest Report for October

Elekta AB (OTCMKTS:EKTAY) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totaling 191 shares. Based on an average daily volume of 2,905 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, Elekta has an average rating of “Hold”.

Elekta Price Performance

Shares of OTCMKTS:EKTAY opened at $5.92 on Monday. Elekta has a 1-year low of $4.35 and a 1-year high of $6.93. The firm has a market capitalization of $2.18 billion, a PE ratio of -49.33 and a beta of 1.01. The business’s 50 day moving average is $5.41 and its 200-day moving average is $5.70. The company has a current ratio of 0.86, a quick ratio of 0.62 and a debt-to-equity ratio of 0.45.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings data on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $372.30 million for the quarter. Elekta had a positive return on equity of 13.47% and a negative net margin of 2.38%. Sell-side analysts predict that Elekta will post 0.43 earnings per share for the current year.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company that develops and supplies systems and software for radiation therapy, radiosurgery and related cancer-care applications. Its solutions are designed to help hospitals and clinics treat tumors while supporting more precise, personalized and less invasive care.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, magnetic resonance-guided radiation therapy technology and brachytherapy products. Elekta also provides oncology information systems and workflow software, including platforms used for treatment planning, patient management and clinical data coordination.

Founded in 1972 by neurosurgeon and inventor Lars Leksell, Elekta initially focused on radiosurgery and later expanded into broader radiation oncology.